Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AL Amyloidosis (AL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06855121
What this trial is testing

The Norwegian Immunotherapy in Multiple Myeloma Study

Who this might be right for
Myeloma MultiplePlasma Cell LeukemiaAL Amyloidosis
St. Olavs Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00298766
What this trial is testing

Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis

Who this might be right for
Amyloidosis
Millennium Pharmaceuticals, Inc. 70
Early research (Phase 1)Ended earlyNCT04115956
What this trial is testing

A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Oncopeptides AB 6
Not applicableLooking for participantsNCT04924998
What this trial is testing

Clinical Study for AL-CM

Who this might be right for
Immunoglobulin Light Amyloidosis Cardiomyopathy
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Testing effectiveness (Phase 2)Study completedNCT03678259
What this trial is testing

124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis

Who this might be right for
Systemic Amyloidosis
University of Tennessee Graduate School of Medicine 57
Early research (Phase 1)Looking for participantsNCT05652335
What this trial is testing

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC 180
Large-scale testing (Phase 3)Not Yet RecruitingNCT07793422
What this trial is testing

Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) Amyloidosis

Who this might be right for
Amyloid Light Chain (AL) Amyloidosis
AbbVie 370
Not applicableUnknownNCT05277493
What this trial is testing

A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab

Who this might be right for
AL Amyloidosis
Peking Union Medical College Hospital 500
Not applicableStudy completedNCT04937777
What this trial is testing

A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 4,481
Testing effectiveness (Phase 2)Active Not RecruitingNCT06649695
What this trial is testing

A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 30
Early research (Phase 1)Ended earlyNCT00030381
What this trial is testing

Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Looking for participantsNCT07110844
What this trial is testing

Teclistamab-Daratumumab in AL Amyloidosis

Who this might be right for
Amyloid Light-chain Amyloidosis
Rajshekhar Chakraborty, MD 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04270175
What this trial is testing

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

Who this might be right for
AmyloidAL AmyloidosisRefractory AL Amyloidosis
Weill Medical College of Cornell University 15
Large-scale testing (Phase 3)Study completedNCT01277016
What this trial is testing

A Trial for Systemic Light-chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 110
Large-scale testing (Phase 3)Study completedNCT03201965
What this trial is testing

Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Amyloidosis
Janssen Research & Development, LLC 416
Not applicableLooking for participantsNCT06205953
What this trial is testing

A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)

Who this might be right for
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 400
Testing effectiveness (Phase 2)Ended earlyNCT03168906
What this trial is testing

Renal AL Amyloid Involvement and NEOD001

Who this might be right for
Amyloidosis
Tufts Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01707264
What this trial is testing

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
Primary Amyloidosis
Prothena Biosciences Ltd. 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT03618537
What this trial is testing

Ixazomib Maintenance Study in Patients With AL Amyloidosis

Who this might be right for
AL Amyloidosis
Memorial Sloan Kettering Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT02816476
What this trial is testing

Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis

Who this might be right for
Amyloidosis
University Hospital, Limoges 40
Next Page